COVID-19 Impact on Global Prostate Cancer Medicine Market Size, Status and Forecast 2020-2026

August 2020 | 93 pages | ID: C83D2BD1CD0AEN
QYResearch

Abstracts

This report focuses on the global Prostate Cancer Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostate Cancer Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• AstraZeneca plc
• Active Biotech
• Bristol Myers-Squibb
• Teva Pharmaceuticals Industries Ltd.
• Johnson & Johnson
• Pfizer Inc.
• Bayer AG
• Abbott Laboratories
• Astellas Pharma Inc.
• Roche Holding AG

Market segment by Type, the product can be split into

• LHRH Antagonists
• LHRH Analogs
• Antiandrogens
• Pipeline Drugs for Hormonal Therapy

Market segment by Application, split into

• Hospitals
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Prostate Cancer Medicine status, future forecast, growth opportunity, key market and key players.
• To present the Prostate Cancer Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Prostate Cancer Medicine are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prostate Cancer Medicine Revenue
1.4 Market Analysis by Type
  1.4.1 Global Prostate Cancer Medicine Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 LHRH Antagonists
  1.4.3 LHRH Analogs
  1.4.4 Antiandrogens
  1.4.5 Pipeline Drugs for Hormonal Therapy
1.5 Market by Application
  1.5.1 Global Prostate Cancer Medicine Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Other
1.6 Coronavirus Disease 2019 (Covid-19): Prostate Cancer Medicine Industry Impact
  1.6.1 How the Covid-19 is Affecting the Prostate Cancer Medicine Industry
    1.6.1.1 Prostate Cancer Medicine Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Prostate Cancer Medicine Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Prostate Cancer Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Prostate Cancer Medicine Market Perspective (2015-2026)
2.2 Prostate Cancer Medicine Growth Trends by Regions
  2.2.1 Prostate Cancer Medicine Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Prostate Cancer Medicine Historic Market Share by Regions (2015-2020)
  2.2.3 Prostate Cancer Medicine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Prostate Cancer Medicine Market Growth Strategy
  2.3.6 Primary Interviews with Key Prostate Cancer Medicine Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Prostate Cancer Medicine Players by Market Size
  3.1.1 Global Top Prostate Cancer Medicine Players by Revenue (2015-2020)
  3.1.2 Global Prostate Cancer Medicine Revenue Market Share by Players (2015-2020)
  3.1.3 Global Prostate Cancer Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Prostate Cancer Medicine Market Concentration Ratio
  3.2.1 Global Prostate Cancer Medicine Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Prostate Cancer Medicine Revenue in 2019
3.3 Prostate Cancer Medicine Key Players Head office and Area Served
3.4 Key Players Prostate Cancer Medicine Product Solution and Service
3.5 Date of Enter into Prostate Cancer Medicine Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Prostate Cancer Medicine Historic Market Size by Type (2015-2020)
4.2 Global Prostate Cancer Medicine Forecasted Market Size by Type (2021-2026)

5 PROSTATE CANCER MEDICINE BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Prostate Cancer Medicine Market Size by Application (2015-2020)
5.2 Global Prostate Cancer Medicine Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Prostate Cancer Medicine Market Size (2015-2020)
6.2 Prostate Cancer Medicine Key Players in North America (2019-2020)
6.3 North America Prostate Cancer Medicine Market Size by Type (2015-2020)
6.4 North America Prostate Cancer Medicine Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Prostate Cancer Medicine Market Size (2015-2020)
7.2 Prostate Cancer Medicine Key Players in Europe (2019-2020)
7.3 Europe Prostate Cancer Medicine Market Size by Type (2015-2020)
7.4 Europe Prostate Cancer Medicine Market Size by Application (2015-2020)

8 CHINA

8.1 China Prostate Cancer Medicine Market Size (2015-2020)
8.2 Prostate Cancer Medicine Key Players in China (2019-2020)
8.3 China Prostate Cancer Medicine Market Size by Type (2015-2020)
8.4 China Prostate Cancer Medicine Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Prostate Cancer Medicine Market Size (2015-2020)
9.2 Prostate Cancer Medicine Key Players in Japan (2019-2020)
9.3 Japan Prostate Cancer Medicine Market Size by Type (2015-2020)
9.4 Japan Prostate Cancer Medicine Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Prostate Cancer Medicine Market Size (2015-2020)
10.2 Prostate Cancer Medicine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Prostate Cancer Medicine Market Size by Type (2015-2020)
10.4 Southeast Asia Prostate Cancer Medicine Market Size by Application (2015-2020)

11 INDIA

11.1 India Prostate Cancer Medicine Market Size (2015-2020)
11.2 Prostate Cancer Medicine Key Players in India (2019-2020)
11.3 India Prostate Cancer Medicine Market Size by Type (2015-2020)
11.4 India Prostate Cancer Medicine Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Prostate Cancer Medicine Market Size (2015-2020)
12.2 Prostate Cancer Medicine Key Players in Central & South America (2019-2020)
12.3 Central & South America Prostate Cancer Medicine Market Size by Type (2015-2020)
12.4 Central & South America Prostate Cancer Medicine Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 AstraZeneca plc
  13.1.1 AstraZeneca plc Company Details
  13.1.2 AstraZeneca plc Business Overview and Its Total Revenue
  13.1.3 AstraZeneca plc Prostate Cancer Medicine Introduction
  13.1.4 AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2015-2020))
  13.1.5 AstraZeneca plc Recent Development
13.2 Active Biotech
  13.2.1 Active Biotech Company Details
  13.2.2 Active Biotech Business Overview and Its Total Revenue
  13.2.3 Active Biotech Prostate Cancer Medicine Introduction
  13.2.4 Active Biotech Revenue in Prostate Cancer Medicine Business (2015-2020)
  13.2.5 Active Biotech Recent Development
13.3 Bristol Myers-Squibb
  13.3.1 Bristol Myers-Squibb Company Details
  13.3.2 Bristol Myers-Squibb Business Overview and Its Total Revenue
  13.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Introduction
  13.3.4 Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2015-2020)
  13.3.5 Bristol Myers-Squibb Recent Development
13.4 Teva Pharmaceuticals Industries Ltd.
  13.4.1 Teva Pharmaceuticals Industries Ltd. Company Details
  13.4.2 Teva Pharmaceuticals Industries Ltd. Business Overview and Its Total Revenue
  13.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Introduction
  13.4.4 Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2015-2020)
  13.4.5 Teva Pharmaceuticals Industries Ltd. Recent Development
13.5 Johnson & Johnson
  13.5.1 Johnson & Johnson Company Details
  13.5.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.5.3 Johnson & Johnson Prostate Cancer Medicine Introduction
  13.5.4 Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2015-2020)
  13.5.5 Johnson & Johnson Recent Development
13.6 Pfizer Inc.
  13.6.1 Pfizer Inc. Company Details
  13.6.2 Pfizer Inc. Business Overview and Its Total Revenue
  13.6.3 Pfizer Inc. Prostate Cancer Medicine Introduction
  13.6.4 Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2015-2020)
  13.6.5 Pfizer Inc. Recent Development
13.7 Bayer AG
  13.7.1 Bayer AG Company Details
  13.7.2 Bayer AG Business Overview and Its Total Revenue
  13.7.3 Bayer AG Prostate Cancer Medicine Introduction
  13.7.4 Bayer AG Revenue in Prostate Cancer Medicine Business (2015-2020)
  13.7.5 Bayer AG Recent Development
13.8 Abbott Laboratories
  13.8.1 Abbott Laboratories Company Details
  13.8.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.8.3 Abbott Laboratories Prostate Cancer Medicine Introduction
  13.8.4 Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2015-2020)
  13.8.5 Abbott Laboratories Recent Development
13.9 Astellas Pharma Inc.
  13.9.1 Astellas Pharma Inc. Company Details
  13.9.2 Astellas Pharma Inc. Business Overview and Its Total Revenue
  13.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Introduction
  13.9.4 Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2015-2020)
  13.9.5 Astellas Pharma Inc. Recent Development
13.10 Roche Holding AG
  13.10.1 Roche Holding AG Company Details
  13.10.2 Roche Holding AG Business Overview and Its Total Revenue
  13.10.3 Roche Holding AG Prostate Cancer Medicine Introduction
  13.10.4 Roche Holding AG Revenue in Prostate Cancer Medicine Business (2015-2020)
  13.10.5 Roche Holding AG Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Prostate Cancer Medicine Key Market Segments
Table 2. Key Players Covered: Ranking by Prostate Cancer Medicine Revenue
Table 3. Ranking of Global Top Prostate Cancer Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Prostate Cancer Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of LHRH Antagonists
Table 6. Key Players of LHRH Analogs
Table 7. Key Players of Antiandrogens
Table 8. Key Players of Pipeline Drugs for Hormonal Therapy
Table 9. COVID-19 Impact Global Market: (Four Prostate Cancer Medicine Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Prostate Cancer Medicine Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Prostate Cancer Medicine Players to Combat Covid-19 Impact
Table 14. Global Prostate Cancer Medicine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Prostate Cancer Medicine Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Prostate Cancer Medicine Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Prostate Cancer Medicine Market Share by Regions (2015-2020)
Table 18. Global Prostate Cancer Medicine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Prostate Cancer Medicine Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Prostate Cancer Medicine Market Growth Strategy
Table 24. Main Points Interviewed from Key Prostate Cancer Medicine Players
Table 25. Global Prostate Cancer Medicine Revenue by Players (2015-2020) (Million US$)
Table 26. Global Prostate Cancer Medicine Market Share by Players (2015-2020)
Table 27. Global Top Prostate Cancer Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Medicine as of 2019)
Table 28. Global Prostate Cancer Medicine by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Prostate Cancer Medicine Product Solution and Service
Table 31. Date of Enter into Prostate Cancer Medicine Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Prostate Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 34. Global Prostate Cancer Medicine Market Size Share by Type (2015-2020)
Table 35. Global Prostate Cancer Medicine Revenue Market Share by Type (2021-2026)
Table 36. Global Prostate Cancer Medicine Market Size Share by Application (2015-2020)
Table 37. Global Prostate Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 38. Global Prostate Cancer Medicine Market Size Share by Application (2021-2026)
Table 39. North America Key Players Prostate Cancer Medicine Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Prostate Cancer Medicine Market Share (2019-2020)
Table 41. North America Prostate Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 42. North America Prostate Cancer Medicine Market Share by Type (2015-2020)
Table 43. North America Prostate Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 44. North America Prostate Cancer Medicine Market Share by Application (2015-2020)
Table 45. Europe Key Players Prostate Cancer Medicine Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Prostate Cancer Medicine Market Share (2019-2020)
Table 47. Europe Prostate Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Prostate Cancer Medicine Market Share by Type (2015-2020)
Table 49. Europe Prostate Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Prostate Cancer Medicine Market Share by Application (2015-2020)
Table 51. China Key Players Prostate Cancer Medicine Revenue (2019-2020) (Million US$)
Table 52. China Key Players Prostate Cancer Medicine Market Share (2019-2020)
Table 53. China Prostate Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 54. China Prostate Cancer Medicine Market Share by Type (2015-2020)
Table 55. China Prostate Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 56. China Prostate Cancer Medicine Market Share by Application (2015-2020)
Table 57. Japan Key Players Prostate Cancer Medicine Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Prostate Cancer Medicine Market Share (2019-2020)
Table 59. Japan Prostate Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Prostate Cancer Medicine Market Share by Type (2015-2020)
Table 61. Japan Prostate Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Prostate Cancer Medicine Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Prostate Cancer Medicine Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Prostate Cancer Medicine Market Share (2019-2020)
Table 65. Southeast Asia Prostate Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Prostate Cancer Medicine Market Share by Type (2015-2020)
Table 67. Southeast Asia Prostate Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Prostate Cancer Medicine Market Share by Application (2015-2020)
Table 69. India Key Players Prostate Cancer Medicine Revenue (2019-2020) (Million US$)
Table 70. India Key Players Prostate Cancer Medicine Market Share (2019-2020)
Table 71. India Prostate Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 72. India Prostate Cancer Medicine Market Share by Type (2015-2020)
Table 73. India Prostate Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 74. India Prostate Cancer Medicine Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Prostate Cancer Medicine Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Prostate Cancer Medicine Market Share (2019-2020)
Table 77. Central & South America Prostate Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Prostate Cancer Medicine Market Share by Type (2015-2020)
Table 79. Central & South America Prostate Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Prostate Cancer Medicine Market Share by Application (2015-2020)
Table 81. AstraZeneca plc Company Details
Table 82. AstraZeneca plc Business Overview
Table 83. AstraZeneca plc Product
Table 84. AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 85. AstraZeneca plc Recent Development
Table 86. Active Biotech Company Details
Table 87. Active Biotech Business Overview
Table 88. Active Biotech Product
Table 89. Active Biotech Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 90. Active Biotech Recent Development
Table 91. Bristol Myers-Squibb Company Details
Table 92. Bristol Myers-Squibb Business Overview
Table 93. Bristol Myers-Squibb Product
Table 94. Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 95. Bristol Myers-Squibb Recent Development
Table 96. Teva Pharmaceuticals Industries Ltd. Company Details
Table 97. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 98. Teva Pharmaceuticals Industries Ltd. Product
Table 99. Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 100. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 101. Johnson & Johnson Company Details
Table 102. Johnson & Johnson Business Overview
Table 103. Johnson & Johnson Product
Table 104. Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 105. Johnson & Johnson Recent Development
Table 106. Pfizer Inc. Company Details
Table 107. Pfizer Inc. Business Overview
Table 108. Pfizer Inc. Product
Table 109. Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 110. Pfizer Inc. Recent Development
Table 111. Bayer AG Company Details
Table 112. Bayer AG Business Overview
Table 113. Bayer AG Product
Table 114. Bayer AG Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 115. Bayer AG Recent Development
Table 116. Abbott Laboratories Business Overview
Table 117. Abbott Laboratories Product
Table 118. Abbott Laboratories Company Details
Table 119. Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 120. Abbott Laboratories Recent Development
Table 121. Astellas Pharma Inc. Company Details
Table 122. Astellas Pharma Inc. Business Overview
Table 123. Astellas Pharma Inc. Product
Table 124. Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 125. Astellas Pharma Inc. Recent Development
Table 126. Roche Holding AG Company Details
Table 127. Roche Holding AG Business Overview
Table 128. Roche Holding AG Product
Table 129. Roche Holding AG Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 130. Roche Holding AG Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Prostate Cancer Medicine Market Share by Type: 2020 VS 2026
Figure 2. LHRH Antagonists Features
Figure 3. LHRH Analogs Features
Figure 4. Antiandrogens Features
Figure 5. Pipeline Drugs for Hormonal Therapy Features
Figure 6. Global Prostate Cancer Medicine Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Other Case Studies
Figure 9. Prostate Cancer Medicine Report Years Considered
Figure 10. Global Prostate Cancer Medicine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Prostate Cancer Medicine Market Share by Regions: 2020 VS 2026
Figure 12. Global Prostate Cancer Medicine Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Prostate Cancer Medicine Market Share by Players in 2019
Figure 15. Global Top Prostate Cancer Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Medicine as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Prostate Cancer Medicine Revenue in 2019
Figure 17. North America Prostate Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Prostate Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Prostate Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Prostate Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Prostate Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Prostate Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Prostate Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. AstraZeneca plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. AstraZeneca plc Revenue Growth Rate in Prostate Cancer Medicine Business (2015-2020)
Figure 26. Active Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Active Biotech Revenue Growth Rate in Prostate Cancer Medicine Business (2015-2020)
Figure 28. Bristol Myers-Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Bristol Myers-Squibb Revenue Growth Rate in Prostate Cancer Medicine Business (2015-2020)
Figure 30. Teva Pharmaceuticals Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Prostate Cancer Medicine Business (2015-2020)
Figure 32. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Medicine Business (2015-2020)
Figure 34. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Pfizer Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2015-2020)
Figure 36. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bayer AG Revenue Growth Rate in Prostate Cancer Medicine Business (2015-2020)
Figure 38. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Abbott Laboratories Revenue Growth Rate in Prostate Cancer Medicine Business (2015-2020)
Figure 40. Astellas Pharma Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Astellas Pharma Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2015-2020)
Figure 42. Roche Holding AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Roche Holding AG Revenue Growth Rate in Prostate Cancer Medicine Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed